menu search

Is spdr s&p pharmaceuticals etf (xph) a strong etf right now?

Smart Beta ETF report for XPH...

January 27, 2022, 7:43 am

Vertex pharmaceuticals, inc. (vrtx) ceo reshma kewalramani on q4 2021 results - earnings call transcript

Vertex pharmaceuticals, Inc. (VRTX) CEO Reshma Kewalramani on Q4 2021 Results - Earnings Call Transcrip...

January 26, 2022, 9:31 pm

Vertex pharmaceuticals, inc. (vrtx) ceo reshma kewalramani on q4 2021 results - earnings call transcript

Vertex pharmaceuticals, Inc. (VRTX) CEO Reshma Kewalramani on Q4 2021 Results - Earnings Call Transcrip...

January 26, 2022, 9:31 pm

Vertex pharmaceuticals, inc. (vrtx) ceo reshma kewalramani on q4 2021 results - earnings call transcript

Vertex pharmaceuticals, Inc. (VRTX) CEO Reshma Kewalramani on Q4 2021 Results - Earnings Call Transcrip...

January 26, 2022, 9:31 pm

Vertex pharmaceuticals (vrtx) surpasses q4 earnings and revenue estimates

Vertex (VRTX) delivered earnings and revenue surprises of 2.74% and 4.01%, respectively, for the quarter ended December 2021. Do the numbers hold clue...

January 26, 2022, 6:25 pm

Vertex pharmaceuticals (vrtx) surpasses q4 earnings and revenue estimates

Vertex (VRTX) delivered earnings and revenue surprises of 2.74% and 4.01%, respectively, for the quarter ended December 2021. Do the numbers hold clue...

January 26, 2022, 6:25 pm

Vertex pharmaceuticals (vrtx) surpasses q4 earnings and revenue estimates

Vertex (VRTX) delivered earnings and revenue surprises of 2.74% and 4.01%, respectively, for the quarter ended December 2021. Do the numbers hold clue...

January 26, 2022, 6:25 pm

Biondvax to present at edison group's open house conference

JERUSALEM, Jan. 26, 2022 /PRNewswire/ -- BiondVax pharmaceuticals Ltd. (Nasdaq: BVXV), a bio...

January 26, 2022, 7:39 am

Biondvax to present at edison group's open house conference

JERUSALEM, Jan. 26, 2022 /PRNewswire/ -- BiondVax pharmaceuticals Ltd. (Nasdaq: BVXV), a bio...

January 26, 2022, 7:39 am

Biondvax to present at edison group's open house conference

JERUSALEM, Jan. 26, 2022 /PRNewswire/ -- BiondVax pharmaceuticals Ltd. (Nasdaq: BVXV), a bio...

January 26, 2022, 7:39 am

Johnson & johnson readies to spin off business units as covid effects linger in 2022

Moving to split its consumer health and medical device/pharma units into two separate public companies, the Johnson & Johnson (JNJ) version of “divi...

January 25, 2022, 1:35 pm

Johnson & johnson readies to spin off business units as covid effects linger in 2022

Moving to split its consumer health and medical device/pharma units into two separate public companies, the Johnson & Johnson (JNJ) version of “divi...

January 25, 2022, 1:35 pm

Johnson & johnson readies to spin off business units as covid effects linger in 2022

Moving to split its consumer health and medical device/pharma units into two separate public companies, the Johnson & Johnson (JNJ) version of “divi...

January 25, 2022, 1:35 pm

Andreas halvorsen gets in on amylyx pharmaceuticals' ipo

Andreas Halvorsen (Trades, Portfolio), chief investment officer of Viking Global Investors, disclosed a stake in Amylyx ...

January 25, 2022, 12:59 pm

Andreas halvorsen gets in on amylyx pharmaceuticals' ipo

Andreas Halvorsen (Trades, Portfolio), chief investment officer of Viking Global Investors, disclosed a stake in Amylyx ...

January 25, 2022, 12:59 pm

Andreas halvorsen gets in on amylyx pharmaceuticals' ipo

Andreas Halvorsen (Trades, Portfolio), chief investment officer of Viking Global Investors, disclosed a stake in Amylyx ...

January 25, 2022, 12:59 pm

Respirerx pharmaceuticals notes publication of paper on gabakine krm-ii-81, which it is advancing for epilepsy and pain

RespireRx pharmaceuticals (OTCQB:RSPI) Inc revealed that scientists associated with the company have pu...

January 25, 2022, 8:43 am

Respirerx pharmaceuticals notes publication of paper on gabakine krm-ii-81, which it is advancing for epilepsy and pain

RespireRx pharmaceuticals (OTCQB:RSPI) Inc revealed that scientists associated with the company have pu...

January 25, 2022, 8:43 am

Respirerx pharmaceuticals notes publication of paper on gabakine krm-ii-81, which it is advancing for epilepsy and pain

RespireRx pharmaceuticals (OTCQB:RSPI) Inc revealed that scientists associated with the company have pu...

January 25, 2022, 8:43 am

Diamedica therapeutics to present research at international stroke conference

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical...

January 25, 2022, 8:43 am


Search within

Pages Search Results: